biote Corp. $BTMD Stock Position Lessened by Bandera Partners LLC

Bandera Partners LLC decreased its position in shares of biote Corp. (NASDAQ:BTMD) by 6.2% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,283,791 shares of the company’s stock after selling 151,844 shares during the period. biote accounts for 4.1% of Bandera Partners LLC’s holdings, making the stock its 8th biggest position. Bandera Partners LLC owned 4.17% of biote worth $9,181,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of BTMD. Nuveen LLC purchased a new stake in shares of biote during the 1st quarter valued at $872,000. Strs Ohio acquired a new position in biote during the 1st quarter valued at about $312,000. Acadian Asset Management LLC raised its stake in biote by 15.0% in the first quarter. Acadian Asset Management LLC now owns 700,871 shares of the company’s stock valued at $2,330,000 after buying an additional 91,672 shares during the last quarter. Hillsdale Investment Management Inc. boosted its holdings in biote by 24.2% in the second quarter. Hillsdale Investment Management Inc. now owns 420,273 shares of the company’s stock worth $1,689,000 after acquiring an additional 81,829 shares in the last quarter. Finally, Heron Bay Capital Management purchased a new stake in shares of biote during the second quarter worth about $173,000. 21.68% of the stock is owned by hedge funds and other institutional investors.

biote Stock Down 3.4%

Shares of NASDAQ BTMD opened at $2.53 on Tuesday. The firm has a market cap of $115.53 million, a price-to-earnings ratio of 2.81 and a beta of 1.15. The company’s 50-day simple moving average is $2.86 and its 200-day simple moving average is $3.44. biote Corp. has a 52-week low of $2.32 and a 52-week high of $6.98.

biote (NASDAQ:BTMD) last issued its quarterly earnings results on Wednesday, November 5th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.05 by $0.17. biote had a net margin of 15.73% and a negative return on equity of 21.00%. The firm had revenue of $47.96 million for the quarter, compared to analyst estimates of $47.76 million. biote has set its FY 2025 guidance at EPS. Equities research analysts anticipate that biote Corp. will post 0.75 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Wall Street Zen lowered shares of biote from a “buy” rating to a “hold” rating in a research report on Sunday, November 2nd. B. Riley reaffirmed a “neutral” rating on shares of biote in a report on Thursday, November 6th. Finally, Weiss Ratings reissued a “sell (d+)” rating on shares of biote in a report on Wednesday, November 19th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, biote presently has a consensus rating of “Hold” and a consensus target price of $6.00.

biote Company Profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.